by chris | Dec 6, 2024 | Uncategorized
UP Oncolytics, Inc’s program to develop Zika Virus strains to treat glioblastoma has achieved two major milestones SBIR Fast Track Grant from the NINDS Orphan Drug Designation from the FDA “In the nearly 40 years I have been caring for glioblastoma patients, prognosis...
